# Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU Study

> **NCT01271842** · — · COMPLETED · sponsor: **Institut National de la Santé Et de la Recherche Médicale, France** · enrollment: 38 (actual)

## Conditions studied

- Influenza
- Pneumonia, Viral
- Pulmonary Fibrosis
- Quality of Life
- Stress Disorders, Post Traumatic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01271842
- **Lead sponsor:** Institut National de la Santé Et de la Recherche Médicale, France
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-10-02
- **Final completion:** 2011-10-02
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2025-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01271842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01271842, "Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01271842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*